TELA Bio (TELA) Gross Profit (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.98% |
| Dec 31, 2025 | -1.53% |
| Sep 30, 2025 | -0.96% |
| Jun 30, 2025 | 12.73% |
| Mar 31, 2025 | 11.51% |
| Dec 31, 2024 | -12.73% |
| Sep 30, 2024 | 16.12% |
| Jun 30, 2024 | -2.32% |
| Mar 31, 2024 | -2.48% |
| Dec 31, 2023 | 11.89% |
| Sep 30, 2023 | 1.84% |
| Jun 30, 2023 | 29.16% |
| Mar 31, 2023 | -3.40% |
| Dec 31, 2022 | 11.71% |
| Sep 30, 2022 | 11.74% |
| Jun 30, 2022 | 31.03% |
| Mar 31, 2022 | -11.66% |
| Dec 31, 2021 | 22.97% |
| Sep 30, 2021 | -9.53% |
| Jun 30, 2021 | 46.81% |
| Mar 31, 2021 | -5.38% |
| Dec 31, 2020 | 11.41% |
| Sep 30, 2020 | 57.65% |
| Jun 30, 2020 | -5.23% |
| Mar 31, 2020 | -25.75% |
| Dec 31, 2019 | 13.79% |
| Sep 30, 2019 | 36.55% |
| Jun 30, 2019 | 6.06% |
| Mar 31, 2019 | 74.90% |
| Dec 31, 2018 | -24.80% |